MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
申请人:Sheppeck James E.
公开号:US20100076014A1
公开(公告)日:2010-03-25
Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein (Ia) is heterocycle or heteroaryl; J, Ja, E, F, G, Ma, M, Q, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.
提供了一些新型非类固醇化合物,其在治疗与糖皮质激素受体、AP-1和/或NF-κB活性调节有关的疾病方面具有用途,包括炎症和免疫性疾病、肥胖和糖尿病,其结构为公式(I),其对映体、顺反异构体或其药学上可接受的盐或水合物,其中(Ia)为杂环或杂芳烃;J,Ja,E,F,G,Ma,M,Q,Za和Z的定义如本文所述。还提供了使用所述化合物治疗炎症或免疫相关疾病、肥胖和糖尿病的药物组合物和方法。